Company intelligence / Profile preview
Glenmark Specialty
Switzerland
- Ownership
- Private
- Employees
- ~14000
- Development stage
- Other
01
Overview
Glenmark Specialty SA, the innovation-driven R&D arm of Glenmark Pharmaceuticals, leads clinical development in oncology and immunology. Key programs include GRC 54276 (HPK1 inhibitor in Phase 1/2 for advanced tumors/lymphomas), ISB 2001 (trispecific antibody for multiple myeloma in Phase 1), and out-licensed monoclonal antibodies for atopic dermatitis (Phase 2b) and hidradenitis suppurativa (Phase 1). The company also has a commercialized asset, RYALTRIS/GSP 301 nasal spray for allergic rhinitis.
- Therapeutic areas
- ImmunologyOncologyNeurologyDermatology
- Modalities
- Small moleculeMonoclonal antibodyBiologicTrispecific monoclonal antibodyNK cell engager
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Ichnos Sciences (Ichnos Glenmark Innovation, oncology R&D)Merck (diabetes drug out-licensing)Several companies (pipeline licensing partnerships in immunology)
Beyond the preview
Go deeper on Glenmark Specialty.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glenmark Specialty.